News

The Malaysian Reserve3h
The drug discovery research for lecanemab awarded the 9th Bioindustry Award by the Japan Bioindustry Association
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the drug discovery research ...
Breast cancer survivors were less likely to get Alzheimer’s if they underwent this treatment: study
The number of Americans diagnosed with Alzheimer’s each year is expected to double by 2060, with the majority of cases affecting women.
Acumen Pharmaceuticals, Inc.: Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery ...
Acumen and JCR aim to develop a product leveraging Acumen's amyloid beta oligomer-selective antibody expertise and JCR's transferrin-receptor-targeting blood-brain barrier-penetrating technologyPrecli ...
AlzeCure Pharma: AlzeCure's Pain Project ACD440 Granted Orphan Drug Status in the US by the FDA
STOCKHOLM, SE / ACCESS Newswire / July 15, 2025 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases ...
Naturopathic Doctor News and Review15h
Tauroursodeoxycholic Acid (TUDCA) And Protective Role Against Neurodegeneration
Emerging research positions TUDCA, a bile acid compound, as a promising neuroprotective agent against Alzheimer’s, ...
Explained Interview | After obesity and diabetes, where GLP-1 research is headed
Lotte Bjerre Knudsen, Chief Scientific Adviser for Research at Danish pharma giant Novo Nordisk, speaks about GLP-1-based ...